SAGE Therapeutics Inc SAGE:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 10/15/21 EDT
44.94UNCH (UNCH)
Volume
2,767
Close
44.94quote price arrow down-0.95 (-2.07%)
Volume
206,675
52 week range
39.77 - 98.39
Loading...
  • Open46.47
  • Day High46.47
  • Day Low44.90
  • Prev Close45.89
  • 52 Week High98.39
  • 52 Week High Date01/15/21
  • 52 Week Low39.77
  • 52 Week Low Date08/20/21

Key Stats

  • Market Cap2.643B
  • Shares Out58.81M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.85
  • YTD % Change-48.05

KEY STATS

  • Open46.47
  • Day High46.47
  • Day Low44.90
  • Prev Close45.89
  • 52 Week High98.39
  • 52 Week High Date01/15/21
  • 52 Week Low39.77
  • 52 Week Low Date08/20/21
  • Market Cap2.643B
  • Shares Out58.81M
  • 10 Day Average Volume0.39M
  • Dividend-
  • Dividend Yield-
  • Beta1.85
  • YTD % Change-48.05

RATIOS/PROFITABILITY

  • EPS (TTM)11.84
  • P/E (TTM)3.79
  • Fwd P/E (NTM)-6.07
  • EBITDA (TTM)666.43M
  • ROE (TTM)49.91%
  • Revenue (TTM)1.114B
  • Gross Margin (TTM)99.94%
  • Net Margin (TTM)59.80%
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date11/03/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On SAGE Therapeutics Inc

There is no recent news for this security.

Profile

MORE
SAGE Therapeutics, Inc. is a biopharmaceutical company that is focused on developing and commercializing medicines with debilitating disorders of the brain. The Company's product, ZULRESSO (brexanolone) CIV injection, is for the treatment of postpartum depression (PPD), in adults. The Company's products also include ZULRESSO (Brexanolone) CIV Injection, Zuranolone (SAGE-217), SAGE-324 and SAGE-718. Its next advanced product candidate is SAGE-217, is an oral compound that is...
Kevin Starr
Non-Executive Chairman
Barry Greene
President
Kimi Iguchi
Chief Financial Officer
Address
215 1st St
Cambridge, MA
02142-1213
United States

Top Peers

SYMBOLLASTCHG%CHG
MYGN
Myriad Genetics Inc
31.74-0.52-1.61%
EXEL
Exelixis Inc
21.82-0.02-0.09%
MEDP
Medpace Holdings Inc
187.08+0.47+0.25%
GLPG
Galapagos NV
53.52-0.69-1.27%
ACAD
ACADIA Pharmaceuticals Inc
17.51-0.31-1.74%